2008
DOI: 10.1272/manms.4.197
|View full text |Cite
|
Sign up to set email alerts
|

Chemoradiation Therapy with Docetaxel/Fluorouracil/Nedaplatin for the Patients with Esophageal Cancer and Simultaneous Double Primary Malignancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…To the best of our knowledge, only 3 cases of PI during CRT for esophageal cancer have been reported in Japan [5‒7]. Herein, we report the first case of PI following radiation-induced esophagitis due to CRT for mediastinal lymph node metastasis from lung cancer.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…To the best of our knowledge, only 3 cases of PI during CRT for esophageal cancer have been reported in Japan [5‒7]. Herein, we report the first case of PI following radiation-induced esophagitis due to CRT for mediastinal lymph node metastasis from lung cancer.…”
Section: Discussionmentioning
confidence: 93%
“…Three reports have shown the development of PI in patients with esophageal cancer during chemoradiotherapy (CRT) [5][6][7]. However, in lung cancer, there have been several reports of PI development during treatment with cytotoxic chemotherapy agents or epidermal growth factor receptor tyrosine kinase inhibitors [8,9].…”
Section: Introductionmentioning
confidence: 99%